% Expired Patents = 50.0

EPO Patents = 2

Forward Citations = 10

Loading Chart...

12 inventors (with patents filed for the assignee):

Yolande Misseri (4 out of 4 patents)

Benedikt Timmerman (4 out of 5 patents)

Daniel Ladant (3 out of 14 patents)

4. Claude Leclerc (3 out of 25 patents)

5. Xavier-Edmond-Edouard Preville (3 out of 3 patents)

6. Michael Esquerre (2 out of 2 patents)

7. Etienne Joly (2 out of 2 patents)

8. Anne Goubier (2 out of 2 patents)

9. Michael Esquerré (1 out of 1 patent)

10. Marie Momot (1 out of 1 patent)

11. Philippe Bridonneau (1 out of 1 patent)

12. Xavier Preville (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 9982024 - CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses (2018-05-29),

2. 9902947 - CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses (2018-02-27),

3. 9827302 - HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders (2017-11-28),

4. 9499809 - CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses (2016-11-22),

5. 9486524 - Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells (2016-11-08),

6. 9387243 - Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof (2016-07-12),

7. 8637039 - Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof (2014-01-28),

8. 8628779 - Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof (2014-01-14),

Company Overview

Genticel is a biotechnology company focused on developing immunotherapies to prevent and treat HPV-related diseases, such as cervical cancer. The company's lead product candidate, ProCervix, is a therapeutic vaccine designed to induce a specific immune response against HPV. Genticel is committed to improving women's health through innovative treatments and technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#3 in Labège

#2,028 in France

Labège, France

Genticel

Forward Citations = 10

12 inventors:

Yolande Misseri (4 out of 4 patents)

Benedikt Timmerman (4 out of 5 patents)

Daniel Ladant (3 out of 14 patents)

4. Claude Leclerc (3 out of 25 patents)

5. Xavier-Edmond-Edouard Preville (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genticel. Retrieved from https://idiyas.com/company/genticel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]